Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Loss of Gsα early in the osteoblast lineage favors adipogenic differentiation of mesenchymal progenitors and committed osteoblast precursors.

Sinha P, Aarnisalo P, Chubb R, Ono N, Fulzele K, Selig M, Saeed H, Chen M, Weinstein LS, Pajevic PD, Kronenberg HM, Wu JY.

J Bone Miner Res. 2014 Nov;29(11):2414-26. doi: 10.1002/jbmr.2270.

2.

Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice.

Wu JY, Aarnisalo P, Bastepe M, Sinha P, Fulzele K, Selig MK, Chen M, Poulton IJ, Purton LE, Sims NA, Weinstein LS, Kronenberg HM.

J Clin Invest. 2011 Sep;121(9):3492-504. doi: 10.1172/JCI46406. Epub 2011 Aug 1.

3.

Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.

Ghali O, Broux O, Falgayrac G, Haren N, van Leeuwen JP, Penel G, Hardouin P, Chauveau C.

BMC Cell Biol. 2015 Mar 13;16:9. doi: 10.1186/s12860-015-0056-6.

4.

Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch.

Addison WN, Fu MM, Yang HX, Lin Z, Nagano K, Gori F, Baron R.

Mol Cell Biol. 2014 Aug;34(16):3076-85. doi: 10.1128/MCB.00185-14. Epub 2014 Jun 2.

5.

Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.

Gambardella A, Nagaraju CK, O'Shea PJ, Mohanty ST, Kottam L, Pilling J, Sullivan M, Djerbi M, Koopmann W, Croucher PI, Bellantuono I.

J Bone Miner Res. 2011 Apr;26(4):811-21. doi: 10.1002/jbmr.266.

6.

Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.

Biver G, Wang N, Gartland A, Orriss I, Arnett TR, Boeynaems JM, Robaye B.

Stem Cells. 2013 Dec;31(12):2747-58. doi: 10.1002/stem.1411.

7.

Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.

Rickard DJ, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME.

Bone. 2006 Dec;39(6):1361-72. Epub 2006 Aug 10.

PMID:
16904389
8.
9.

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.

Bäckesjö CM, Li Y, Lindgren U, Haldosén LA.

J Bone Miner Res. 2006 Jul;21(7):993-1002.

10.

Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice.

Blair HC, Kalyvioti E, Papachristou NI, Tourkova IL, Syggelos SA, Deligianni D, Orkoula MG, Kontoyannis CG, Karavia EA, Kypreos KE, Papachristou DJ.

Lab Invest. 2016 Jul;96(7):763-72. doi: 10.1038/labinvest.2016.51. Epub 2016 Apr 18.

11.

Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes.

Song L, Liu M, Ono N, Bringhurst FR, Kronenberg HM, Guo J.

J Bone Miner Res. 2012 Nov;27(11):2344-58. doi: 10.1002/jbmr.1694.

12.

Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs).

Martin PJ, Haren N, Ghali O, Clabaut A, Chauveau C, Hardouin P, Broux O.

BMC Cell Biol. 2015 Mar 18;16:10. doi: 10.1186/s12860-015-0057-5.

13.

The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta.

Lee S, Cho HY, Bui HT, Kang D.

BMC Cell Biol. 2014 Nov 25;15:42. doi: 10.1186/s12860-014-0042-4.

14.

Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.

Pignolo RJ, Xu M, Russell E, Richardson A, Kaplan J, Billings PC, Kaplan FS, Shore EM.

J Bone Miner Res. 2011 Nov;26(11):2647-55. doi: 10.1002/jbmr.481.

15.

Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.

Sinha P, Aarnisalo P, Chubb R, Poulton IJ, Guo J, Nachtrab G, Kimura T, Swami S, Saeed H, Chen M, Weinstein LS, Schipani E, Sims NA, Kronenberg HM, Wu JY.

J Biol Chem. 2016 Jan 22;291(4):1631-42. doi: 10.1074/jbc.M115.679753. Epub 2015 Nov 23.

16.

Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation.

Xie X, Qin J, Lin SH, Tsai SY, Tsai MJ.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14843-8. doi: 10.1073/pnas.1110236108. Epub 2011 Aug 22.

17.

N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging.

Haÿ E, Dieudonné FX, Saidak Z, Marty C, Brun J, Da Nascimento S, Sonnet P, Marie PJ.

J Cell Physiol. 2014 Nov;229(11):1765-75. doi: 10.1002/jcp.24629.

PMID:
24664975
18.

Gata2 Is a Rheostat for Mesenchymal Stem Cell Fate in Male Mice.

Li X, Huynh H, Zuo H, Salminen M, Wan Y.

Endocrinology. 2016 Mar;157(3):1021-8. doi: 10.1210/en.2015-1827. Epub 2016 Jan 26.

19.
20.

Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts.

Wiren KM, Hashimoto JG, Semirale AA, Zhang XW.

Bone. 2011 Oct;49(4):662-72. doi: 10.1016/j.bone.2011.06.010. Epub 2011 Jun 17.

Supplemental Content

Support Center